~~<i id='E5EE59F766'><strike id='E5EE59F766'><tt id='E5EE59F766'><pre id='E5EE59F766'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：leisure time 2025-10-06 12:58:46 Page View：97598

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： EU climate chief is concerned over the expansion of the coal industry in China
Next article： Moonlake's readout produced a cash windfall. Risks remain

Wikipedia

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Noem? Reynolds? A very early look at the Republican 'veepstakes'

2:30InthisOct.1,2022,filephoto,IowaGovernorspeaksattheIowaStateFairgroundsinDesMoines.|SouthDakotaGo

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

A timeline of the missing Titanic tourist submersible

6:57FileimageoftheTitansubmersiblepriortocommencediving.OceanGateMultinationalsearchandrescueefforts